Company / Current Assets per Share
NeoGenomics Laboratories, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$2.94
FY2025
5-year range
$2.94 / $5.68
FY2021-FY2025
Trend
-37.6%
vs FY2024
Sector context
#141 of 158
Health Care
What the data says
NeoGenomics Laboratories, Inc.'s current assets per share of $2.94 is lower than 89% of companies in the Health Care sector (FY2025). Current Assets per Share has declined for 4 consecutive years, from $5.68 in FY2021 to $2.94 in FY2025.
Based on SEC 10-K filings.
2.94 in FY2025 with a 5-year CAGR of -6.1%.
Declined from $4.76 to $2.94 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -15.5%
- 5-Year CAGR
- -6.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 158This company $2.94 Sector average $54.20
▼
-94.6% below sector average
Key checks
Key Insights
- NeoGenomics Laboratories, Inc.'s current assets per share has declined for 4 consecutive years.
- In FY2025, current assets per share decreased 37.6% year-over-year.
- Ranks #141 out of 158 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.94 | -37.6% |
| FY2024 | $4.71 | -1.0% |
| FY2023 | $4.76 | -2.4% |
| FY2022 | $4.87 | -14.2% |
| FY2021 | $5.68 | +41.5% |
| FY2020 | $4.01 | +43.0% |
| FY2019 | $2.81 | +147.8% |
| FY2018 | $1.13 | +3.6% |
| FY2017 | $1.09 | +5.1% |
| FY2016 | $1.04 | -24.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026